{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:37:20Z","timestamp":1761863840592},"publisher-location":"Singapore","reference-count":66,"publisher":"Springer Singapore","isbn-type":[{"type":"print","value":"9789811075711"},{"type":"electronic","value":"9789811075728"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-981-10-7572-8_9","type":"book-chapter","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T09:17:12Z","timestamp":1526894232000},"page":"103-112","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Challenges in Malaria Management and a Glimpse at Some Nanotechnological Approaches"],"prefix":"10.1007","author":[{"given":"Adrian","family":"Najer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia G.","family":"Palivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"9_CR1","unstructured":"World Health Organization. World Health Statistics (2015) World Health Organization, Geneva, 1\u2013164"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrmicro3519","volume":"13","author":"GA Josling","year":"2015","unstructured":"Josling GA, Llin\u00e1s M (2015) Sexual development in Plasmodium parasites: knowing when it\u2019s time to commit. Nat Rev Micro 13:573\u2013587","journal-title":"Nat Rev Micro"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrg2126","volume":"8","author":"X Su","year":"2007","unstructured":"Su X, Hayton K, Wellems TE (2007) Genetic linkage and association analyses for trait mapping in Plasmodium falciparum. Nat Rev Genet 8:497\u2013506","journal-title":"Nat Rev Genet"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0140-6736(13)60024-0","volume":"383","author":"NJ White","year":"2014","unstructured":"White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM (2014) Malaria. Lancet 383:723\u2013735","journal-title":"Lancet"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1083\/jcb.201206112","volume":"198","author":"AF Cowman","year":"2012","unstructured":"Cowman AF, Berry D, Baum J (2012) The cell biology of disease: the cellular and molecular basis for malaria parasite invasion of the human red blood cell. J Cell Biol 198:961\u2013971","journal-title":"J Cell Biol"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.cell.2006.02.006","volume":"124","author":"AF Cowman","year":"2006","unstructured":"Cowman AF, Crabb BS (2006) Invasion of red blood cells by malaria parasites. Cell 124:755\u2013766","journal-title":"Cell"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S0169-4758(00)01753-1","volume":"16","author":"B Cooke","year":"2000","unstructured":"Cooke B, Coppel R, Wahlgren M (2000) Falciparum malaria: sticking up, standing out and out-standing. Parasitol Today 16:416\u2013420","journal-title":"Parasitol Today"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"19987","DOI":"10.1073\/pnas.1309247110","volume":"110","author":"E Mundwiler-Pachlatko","year":"2013","unstructured":"Mundwiler-Pachlatko E, Beck H-P (2013) Maurer\u2019s clefts, the enigma of Plasmodium falciparum. Proc Natl Acad Sci USA 110:19987\u201319994","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/nature04407","volume":"439","author":"TS Voss","year":"2006","unstructured":"Voss TS, Healer J, Marty AJ, Duffy MF, Thompson JK, Beeson JG et al (2006) A var gene promoter controls allelic exclusion of virulence genes in Plasmodium falciparum malaria. Nature 439:1004\u20131008","journal-title":"Nature"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00232-003-0646-7","volume":"197","author":"H Ginsburg","year":"2004","unstructured":"Ginsburg H, Stein WD (2004) The new permeability pathways induced by the malaria parasite in the membrane of the infected erythrocyte: comparison of results using different experimental techniques. J Membrane Biol 197:113\u2013134","journal-title":"J Membrane Biol"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/353073a0","volume":"353","author":"B Pouvelle","year":"1991","unstructured":"Pouvelle B, Spiegel R, Hsiao L, Howard RJ, Morris RL, Thomas AP et al (1991) Direct access to serum macromolecules by intraerythrocytic malaria parasites. Nature 353:73\u201375","journal-title":"Nature"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0166-6851(97)00039-X","volume":"87","author":"ID Goodyer","year":"1997","unstructured":"Goodyer ID, Pouvelle B, Schneider TG, Trelka DP, Taraschi TF (1997) Characterization of macromolecular transport pathways in malaria-infected erythrocytes. Mol Biochem Parasitol 87:13\u201328","journal-title":"Mol Biochem Parasitol"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-2-11","volume":"2","author":"A Tahir El","year":"2003","unstructured":"El Tahir A, Malhotra P, Chauhan VS (2003) Uptake of proteins and degradation of human serum albumin by Plasmodium falciparum-infected human erythrocytes. Malar J 2:1\u20138","journal-title":"Malar J"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/1475-2875-8-183","volume":"8","author":"ES Bergmann-Leitner","year":"2009","unstructured":"Bergmann-Leitner ES, Duncan EH, Angov E (2009) MSP-1p42-specific antibodies affect growth and development of intra-erythrocytic parasites of Plasmodium falciparum. Malar J 8:183\u2013195","journal-title":"Malar J"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jconrel.2013.12.032","volume":"177","author":"P Urb\u00e1n","year":"2014","unstructured":"Urb\u00e1n P, Valle-Delgado JJ, Mauro N, Marques J, Manfredi A, Rottmann M et al (2014) Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium. J Control Release 177:84\u201395","journal-title":"J Control Release"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1146\/annurev-biochem-060614-034157","volume":"84","author":"NJ Spillman","year":"2015","unstructured":"Spillman NJ, Beck JR, Goldberg DE (2015) Protein export into malaria parasite-infected erythrocytes: mechanisms and functional consequences. Annu Rev Biochem 84:813\u2013841","journal-title":"Annu Rev Biochem"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1126\/science.1184785","volume":"328","author":"SHI Kappe","year":"2010","unstructured":"Kappe SHI, Vaughan AM, Boddey JA, Cowman AF (2010) That was then but this is now: malaria research in the time of an eradication agenda. Science 328:862\u2013866","journal-title":"Science"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J et al (2009) Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361:455\u2013467","journal-title":"N Engl J Med"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","volume":"15","author":"KM Tun","year":"2015","unstructured":"Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T et al (2015) Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis 15:415\u2013421","journal-title":"Lancet Infect Dis"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","volume":"16","author":"C Amaratunga","year":"2016","unstructured":"Amaratunga C, Lim P, Suon S, Sreng S, Mao S (2016) Dihydroartemisinin\u2013piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis 16:357\u2013365","journal-title":"Lancet Infect Dis"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm.3073","volume":"19","author":"LH Miller","year":"2013","unstructured":"Miller LH, Ackerman HC, Su X-Z, Wellems TE (2013) Malaria biology and disease pathogenesis: insights for new treatments. Nat Med 19:156\u2013167","journal-title":"Nat Med"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nrd4573","volume":"14","author":"TNC Wells","year":"2015","unstructured":"Wells TNC, van Huijsduijnen RH, Van Voorhis WC (2015) Malaria medicines: a glass half full? Nat Rev Drug Discov 14:424\u2013442 Nature Publishing Group","journal-title":"Nat Rev Drug Discov"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","volume":"386","author":"SCTP Rts","year":"2015","unstructured":"Rts SCTP (2015) Efficacy and safety of RTS, S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386:31\u201345 Elsevier Ltd.","journal-title":"Lancet"},{"key":"9_CR24","first-page":"33","volume":"91","author":"World Health Organization","year":"2016","unstructured":"World Health Organization (2016) Malaria vaccine: WHO position paper-January 2016. Wkly Epidemiol Rec 91:33\u201351","journal-title":"Wkly Epidemiol Rec"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1126\/science.1241800","volume":"341","author":"RA Seder","year":"2013","unstructured":"Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ et al (2013) Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341:1359\u20131365","journal-title":"Science"},{"key":"9_CR26","doi-asserted-by":"crossref","unstructured":"Ishizuka AS, Lyke KE, DeZure A, Berry AA, Richie TL, Mendoza FH, et al (2016) Protection against malaria at 1\u00a0year and immune correlates following PfSPZ vaccination. Nat Med 1\u201313. Nature Publishing Group","DOI":"10.1038\/nm.4110"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1086\/600120","volume":"200","author":"KE Kester","year":"2009","unstructured":"Kester KE, Cummings JF, Ofori Anyinam O, Ockenhouse CF, Krzych U, Moris P et al (2009) Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS, S\/AS01B and RTS, S\/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection. J Infect Dis 200:337\u2013346","journal-title":"J Infect Dis"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/icb.2009.27","volume":"87","author":"JS Richards","year":"2009","unstructured":"Richards JS, Beeson JG (2009) The future for blood-stage vaccines against malaria. Immunol Cell Biol 87:377\u2013390","journal-title":"Immunol Cell Biol"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4161\/hv.6.1.10396","volume":"6","author":"SL Hoffman","year":"2010","unstructured":"Hoffman SL, Billingsley PF, James E, Richman A, Loyevsky M, Li T et al (2010) Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccines 6:97\u2013106","journal-title":"Hum Vaccines"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12916-015-0384-6","volume":"13","author":"M Tanner","year":"2014","unstructured":"Tanner M, Greenwood B, Whitty CJM, Ansah EK, Price RN, Dondorp AM et al (2014) Malaria eradication and elimination: views on how to translate a vision into reality. BMC Med 13:167","journal-title":"BMC Med"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/S0140-6736(15)00417-1","volume":"387","author":"J Hemingway","year":"2016","unstructured":"Hemingway J, Ranson H, Magill A, Kolaczinski J (2016) Averting a malaria disaster: will insecticide resistance derail malaria control? Lancet 387:1785\u20131788","journal-title":"Lancet"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1073\/pnas.1316253111","volume":"111","author":"EY Lukianova-Hleb","year":"2014","unstructured":"Lukianova-Hleb EY, Campbell KM, Constantinou PE, Braam J, Olson JS, Ware RE et al (2014) Hemozoin-generated vapor nanobubbles for transdermal reagent- and needle-free detection of malaria. Proc Natl Acad Sci USA 111:900\u2013905","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4-5","key":"9_CR33","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.addr.2009.11.024","volume":"62","author":"Nereide Stela Santos-Magalh\u00e3es","year":"2010","unstructured":"Santos-Magalh\u00e3es NS, Mosqueira VCF (2010) Nanotechnology applied to the treatment of malaria. Adv Drug Deliver Rev 62:560\u2013575. Elsevier B.V","journal-title":"Advanced Drug Delivery Reviews"},{"key":"9_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14205\/2310-9386.2015.03.01.1","volume":"3","author":"Dennis E, Peoples VA, Johnson F","year":"2015","unstructured":"Dennis E, Peoples VA, Johnson F (2015) Utilizing Nanotechnology to Combat Malaria. J Infect Dis Ther 3:1\u20136","journal-title":"J Infect Dis Ther"},{"key":"9_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cis.2013.10.014","volume":"201\u2013202","author":"NP Aditya","year":"2013","unstructured":"Aditya NP, Vathsala PG, Vieira V, Murthy RSR, Souto EB (2013) Advances in nanomedicines for malaria treatment. Adv Colloid Interfac 201\u2013202:1\u201317","journal-title":"Adv Colloid Interfac"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/ddr.21010","volume":"73","author":"N Kuntworbe","year":"2012","unstructured":"Kuntworbe N, Martini N, Shaw J, Al-Kassas R (2012) Malaria intervention policies and pharmaceutical nanotechnology as a potential tool for malaria management. Drug Dev Res 73:167\u2013184","journal-title":"Drug Dev Res"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jconrel.2012.04.037","volume":"162","author":"RK Tyagi","year":"2012","unstructured":"Tyagi RK, Garg NK, Sahu T (2012) Vaccination Strategies against Malaria: novel carrier(s) more than a tour de force. J Control Release 162:242\u2013254","journal-title":"J Control Release"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1586\/14760584.2015.1096781","volume":"14","author":"P Burkhard","year":"2015","unstructured":"Burkhard P, Lanar DE (2015) Malaria vaccine based on self-assembling protein nanoparticles. Expert Rev Vaccines 14:1525\u20131527","journal-title":"Expert Rev Vaccines"},{"issue":"27","key":"9_CR39","doi-asserted-by":"publisher","first-page":"7940","DOI":"10.1016\/j.biomaterials.2014.05.061","volume":"35","author":"Julie Movellan","year":"2014","unstructured":"Movellan J, Urb\u00e1n P, Moles E, la Fuente de JM, Sierra T, Serrano JL, et al (2014) Amphiphilic dendritic derivatives as nanocarriers for the targeted delivery of antimalarial drugs. Biomaterials 35:7940\u20137950","journal-title":"Biomaterials"},{"key":"9_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0166-6851(94)90038-8","volume":"66","author":"B Pouvelle","year":"1994","unstructured":"Pouvelle B, Gormley JA, Taraschi TF (1994) Characterization of trafficking pathways and membrane genesis in malaria-infected erythrocytes. Mol Biochem Parasitol 66:83\u201396","journal-title":"Mol Biochem Parasitol"},{"issue":"2","key":"9_CR41","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jconrel.2011.01.001","volume":"151","author":"Patricia Urb\u00e1n","year":"2011","unstructured":"Urb\u00e1n P, Estelrich J, Cort\u00e9s A, Fern\u00e0ndez-Busquets X (2011) A nanovector with complete discrimination for targeted delivery to Plasmodium falciparum-infected versus non-infected red blood cells in vitro. J Control Release 151:202\u2013211. Elsevier B.V","journal-title":"Journal of Controlled Release"},{"key":"9_CR42","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/1556-276X-6-620","volume":"6","author":"P Urb\u00e1n","year":"2011","unstructured":"Urb\u00e1n P, Estelrich J, Adeva A, Cort\u00e9s A, Fern\u00e0ndez-Busquets X (2011) Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors. Nanoscale Res Lett 6:620\u2013630","journal-title":"Nanoscale Res Lett"},{"key":"9_CR43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jconrel.2015.05.284","volume":"210","author":"E Moles","year":"2015","unstructured":"Moles E, Urb\u00e1n P, Jim\u00e9nez-D\u00edaz MB, Viera-Morilla S, Angulo-Barturen I, Busquets MA et al (2015) Immunoliposome-mediated drug delivery to Plasmodium-infected and non-infected red blood cells as a dual therapeutic\/prophylactic antimalarial strategy. J Control Release 210:217\u2013229","journal-title":"J Control Release"},{"key":"9_CR44","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1152\/physrev.2001.81.2.495","volume":"81","author":"K Kirk","year":"2001","unstructured":"Kirk K (2001) Membrane transport in the malaria-infected erythrocyte. Physiol Rev 81:495\u2013537","journal-title":"Physiol Rev"},{"key":"9_CR45","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.nano.2014.06.002","volume":"10","author":"J Marques","year":"2014","unstructured":"Marques J, Moles E, Urb\u00e1n P, Prohens R, Busquets MA, Sevrin C et al (2014) Application of heparin as a dual agent with antimalarial and liposome targeting activities toward Plasmodium-infected red blood cells. Nanomed-Nanotechnol 10:1719\u20131728","journal-title":"Nanomed-Nanotechnol"},{"key":"9_CR46","doi-asserted-by":"publisher","first-page":"833","DOI":"10.4155\/fmc.15.35","volume":"7","author":"E Moles","year":"2015","unstructured":"Moles E, Fern\u00e0ndez-Busquets X (2015) Loading antimalarial drugs into noninfected red blood cells: an undesirable roommate for Plasmodium. Future Med Chem 7:833\u2013835","journal-title":"Future Med Chem"},{"key":"9_CR47","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3109\/08982104.2010.539185","volume":"21","author":"B Isacchi","year":"2011","unstructured":"Isacchi B, Arrigucci S, Marca GL, Bergonzi MC, Vannucchi MG, Novelli A et al (2011) Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice. J Lipos Res 21:237\u2013244","journal-title":"J Lipos Res"},{"issue":"3","key":"9_CR48","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ejpb.2011.11.015","volume":"80","author":"Benedetta Isacchi","year":"2012","unstructured":"Isacchi B, Bergonzi MC, Grazioso M, Righeschi C, Pietretti A, Severini C, et al (2012) Artemisinin and artemisinin plus curcumin liposomal formulations: Enhanced antimalarial efficacy against Plasmodium berghei-infected mice. Eur J Pharm Biopharm 80:528\u2013534. Elsevier B.V","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"8","key":"9_CR49","doi-asserted-by":"publisher","first-page":"e72722","DOI":"10.1371\/journal.pone.0072722","volume":"8","author":"Judith H. Waknine-Grinberg","year":"2013","unstructured":"Waknine-Grinberg JH, Even-Chen S, Avichzer J, Turjeman K, Bentura-Marciano A, Haynes RK, et al (2013) Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria. PLoS ONE 8:e72722. Coban C (ed)","journal-title":"PLoS ONE"},{"key":"9_CR50","first-page":"1","volume":"2014","author":"J Guo","year":"2014","unstructured":"Guo J, Waknine-Grinberg JH, Mitchell AJ, Barenholz Y, Golenser J (2014) Reduction of experimental cerebral malaria and its related proinflammatory responses by the novel liposome-based \u03b2-Methasone nanodrug. Biomed Res Int 2014:1\u20138","journal-title":"Biomed Res Int"},{"key":"9_CR51","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nmat3776","volume":"12","author":"S Mura","year":"2013","unstructured":"Mura S, Nicolas J, Couvreur P (2013) Stimuli-responsive nanocarriers for drug delivery. Nat Mater 12:991\u20131003","journal-title":"Nat Mater"},{"key":"9_CR52","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1039\/C5CS00569H","volume":"45","author":"CG Palivan","year":"2016","unstructured":"Palivan CG, Goers R, Najer A, Zhang X, Car A, Meier W (2016) Bioinspired polymer vesicles and membranes for biological and medical applications. Chem Soc Rev 45:377\u2013411","journal-title":"Chem Soc Rev"},{"issue":"12","key":"9_CR53","doi-asserted-by":"publisher","first-page":"e1003782","DOI":"10.1371\/journal.ppat.1003782","volume":"9","author":"Denis Kasozi","year":"2013","unstructured":"Kasozi D, Mohring F, Rahlfs S, Meyer AJ, Becker K (2013) Real-time imaging of the intracellular glutathione redox potential in the malaria parasite plasmodium falciparum. PLoS Pathog 9:e1003782. Ginsburg H (ed)","journal-title":"PLoS Pathogens"},{"key":"9_CR54","doi-asserted-by":"publisher","first-page":"14858","DOI":"10.1039\/C6NR04290B","volume":"8","author":"A Najer","year":"2016","unstructured":"Najer A, Wu D, Nussbaumer MG, Schwertz G, Schwab A, Witschel MC et al (2016) An amphiphilic graft copolymer-based nanoparticle platform for reduction-responsive anticancer and antimalarial drug delivery. Nanoscale 8:14858\u201314869","journal-title":"Nanoscale"},{"key":"9_CR55","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S0891-5849(01)00480-4","volume":"30","author":"FQ Schafer","year":"2001","unstructured":"Schafer FQ, Buettner GR (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide\/glutathione couple. Free Radic Biol Med 30:1191\u20131212","journal-title":"Free Radic Biol Med"},{"key":"9_CR56","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1021\/jm501987h","volume":"58","author":"MC Witschel","year":"2015","unstructured":"Witschel MC, Rottmann M, Schwab A, Leartsakulpanich U, Chitnumsub P, Seet M et al (2015) Inhibitors of Plasmodial Serine Hydroxymethyltransferase (SHMT): cocrystal structures of pyrazolopyrans with potent blood- and liver-stage activities. J Med Chem 58:3117\u20133130","journal-title":"J Med Chem"},{"key":"9_CR57","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1006\/expr.1995.1099","volume":"81","author":"VL Dubois","year":"1995","unstructured":"Dubois VL, Platel DF, Pauly G, Tribouley-Duret J (1995) Plasmodium berghei: implication of intracellular glutathione and its related enzyme in chloroquine resistance in vivo. Exp Parasitol 81:117\u2013124","journal-title":"Exp Parasitol"},{"issue":"5","key":"9_CR58","doi-asserted-by":"publisher","first-page":"e0128212","DOI":"10.1371\/journal.pone.0128212","volume":"10","author":"Joel Vega-Rodr\u00edguez","year":"2015","unstructured":"Vega-Rodr\u00edguez J, Pastrana-Mena R, Crespo-Llad\u00f3 KN, Ortiz JG, Ferrer-Rodr\u00edguez I, Serrano AE (2015) Implications of glutathione levels in the plasmodium berghei response to chloroquine and artemisinin. PLoS ONE 10:e0128212. Carvalho LH (ed)","journal-title":"PLOS ONE"},{"key":"9_CR59","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2217\/fmb.14.30","volume":"9","author":"K Paaijmans","year":"2014","unstructured":"Paaijmans K, Fern\u00e0ndez-Busquets X (2014) Antimalarial drug delivery to the mosquito: an option worth exploring? Future Microbiol 9:579\u2013582","journal-title":"Future Microbiol"},{"key":"9_CR60","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/nm.3409","volume":"19","author":"SG Reed","year":"2013","unstructured":"Reed SG, Orr MT, Fox CB (2013) Key roles of adjuvants in modern vaccines. Nat Med 19:1597\u20131608","journal-title":"Nat Med"},{"key":"9_CR61","doi-asserted-by":"publisher","first-page":"G67","DOI":"10.1016\/j.vaccine.2009.10.013","volume":"27S","author":"J Vekemans","year":"2009","unstructured":"Vekemans J, Leach A, Cohen J (2009) Development of the RTSS\/AS malaria candidate vaccine. Vaccine 27S:G67\u2013G71","journal-title":"Vaccine"},{"key":"9_CR62","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1128\/IAI.71.8.4749-4758.2003","volume":"71","author":"MS Mueller","year":"2003","unstructured":"Mueller MS, Renard A, Boato F, Vogel D, Naegeli M, Zurbriggen R et al (2003) Induction of Parasite Growth-Inhibitory Antibodies by a Virosomal Formulation of a Peptidomimetic of Loop I from Domain III of Plasmodium falciparum Apical Membrane Antigen 1. Infect Immun 71:4749\u20134758","journal-title":"Infect Immun"},{"key":"9_CR63","doi-asserted-by":"publisher","first-page":"7433","DOI":"10.1016\/j.vaccine.2015.09.093","volume":"33","author":"SJ Draper","year":"2015","unstructured":"Draper SJ, Angov E, Horii T, Miller LH, Srinivasan P, Theisen M et al (2015) Recent advances in recombinant protein-based malaria vaccines. Vaccine 33:7433\u20137443 Elsevier Ltd.","journal-title":"Vaccine"},{"key":"9_CR64","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.coi.2012.03.009","volume":"24","author":"AM Vaughan","year":"2012","unstructured":"Vaughan AM, Kappe SH (2012) Malaria vaccine development: persistent challenges. Curr Opin Immunol 24:324\u2013331 Elsevier Ltd","journal-title":"Curr Opin Immunol"},{"key":"9_CR65","doi-asserted-by":"publisher","first-page":"12560","DOI":"10.1021\/nn5054206","volume":"8","author":"A Najer","year":"2014","unstructured":"Najer A, Wu D, Bieri A, Brand F, Palivan CG, Beck H-P et al (2014) Nanomimics of host cell membranes block invasion and expose invasive malaria parasites. ACS Nano 8:12560\u201312571","journal-title":"ACS Nano"},{"issue":"21","key":"9_CR66","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/marc.201500267","volume":"36","author":"Adrian Najer","year":"2015","unstructured":"Najer A, Thamboo S, Duskey JT, Palivan CG, Beck H-P, Meier W (2015) Analysis of molecular parameters determining the antimalarial activity of polymer-based nanomimics. Macromol Rapid Commun 36:1923\u20131928. Lendlein A, Pandit A (eds)","journal-title":"Macromolecular Rapid Communications"}],"container-title":["Advances in Experimental Medicine and Biology","Infectious Diseases and Nanomedicine III"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-10-7572-8_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T07:47:21Z","timestamp":1571384841000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-10-7572-8_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9789811075711","9789811075728"],"references-count":66,"URL":"https:\/\/doi.org\/10.1007\/978-981-10-7572-8_9","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2018]]}}}